Drooid Logo
Back to story perspectives

Full Breakdown

Impact of U.S. Aid Cuts on HIV Services in Kenya

10/22/2025, 8:54:06 AM

Overview of the HIV Situation in Kenya

Kenya has made significant strides in managing HIV/AIDS, achieving an 83% reduction in new infections, a 68% decrease in HIV-related deaths, and a 65% decline in mother-to-child transmission over the past decade, according to the Ministry of Health. This progress has been largely supported by Overseas Development Assistance, particularly from the U.S. Agency for International Development (USAID) and the President’s Emergency Plan for AIDS Relief (PEPFAR). As of 2023, approximately 1.4 million people live with HIV in Kenya, with 1.3 million receiving antiretroviral therapy (ART).

Consequences of Funding Cuts

The abrupt cuts to foreign aid initiated by former U.S. President Donald Trump have severely impacted HIV services in Kenya. Reports indicate that many lifesaving health programs have either ceased operations or are functioning at minimal capacity. The UNAIDS report from April 2025 highlighted that the withdrawal of USAID funding has significantly affected HIV care, leading to increased risks and uncertainty regarding essential HIV commodities.

Kevin Nato, an HIV peer educator, expressed concern over the scarcity of ART drugs, stating, “I hope that never stops; we’ve heard rumors that the medicines are becoming scarce.” Similarly, Vera Awuor, a peer educator, reported rationing of ARVs, with some patients receiving only a fraction of their usual doses. The cuts have also led to the discontinuation of crucial services, such as cervical cancer screenings for women living with HIV.

Government Response and Integration Efforts

In response to the funding gaps, the Government of Kenya is implementing a policy to integrate HIV services into general healthcare. Maria Mulwa, the HIV Programme Coordinator for Kilifi County, noted that the goal is to provide comprehensive care without stigma. However, critics like Alice Saina, chairperson of the Eldoret Sex Workers Alliance, argue that this integration could deter key populations from seeking necessary services due to fear of judgment.

Nassim Jahangir, Kilifi South Sub-County’s HIV and STI Coordinator, echoed these concerns, stating, “You can’t put them in the regular hospital queue. They don’t like being in spaces where they feel judged.” The integration policy is currently at about 65% completion, but many fear it may not adequately address the specific needs of vulnerable populations.

Broader Implications of Aid Cuts

The cuts to U.S. foreign aid have raised alarms about a potential resurgence in new HIV infections in Kenya. Joseph Sadiki, a long-term HIV survivor, warned that the cessation of foreign aid could undo decades of progress, stating, “Cutting off support for these services feels like a death sentence.” Nelson Otuoma, CEO of the National Empowerment Network of People Living with HIV/AIDS in Kenya (NEPHAK), cautioned that the funding halt could have disastrous consequences for millions of Kenyans living with HIV.

Verbatim Quotes

  • “The first thing I lost was my job as a peer educator,” — Kevin Nato, Peer Educator
  • “ARVs started being rationed. Some patients only received a fraction of their usual dose, while others got nothing at all,” — Vera Awuor, Peer Educator
  • “This policy will kill many people in the key populations because they won’t feel comfortable seeking services in such settings.” — Alice Saina, Chairperson of ESWA
  • “My life depends on ARV drugs. Cutting off support for these services feels like a death sentence,” — Joseph Sadiki, HIV Survivor

Conclusion

The cuts to U.S. foreign aid have exposed the vulnerabilities in Kenya's HIV response, threatening the health and wellbeing of millions. As the government seeks to adapt through service integration, the effectiveness of these measures remains uncertain, particularly for marginalized populations. The ongoing situation underscores the critical need for sustained international support to maintain the progress achieved in HIV management.